FDA rejects wider use of Amag's anemia drug

Jan 22 (Reuters) - Amag Pharmaceuticals Inc said the U.S. Food and Drug Administration rejected its application for a wider use of its iron deficiency drug, sending its shares down 18 percent in...

from Reuters: Hot Stocks http://ift.tt/KG9UD6